(Q47989124)

English

Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice

scientific article published on 17 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

author name string

Mao Horio

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

Yuko Fujita

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

Kenji Hashimoto

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

publication date

17 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

Fundamental and Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

27

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

483-488

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Neurocognitive impairment across the lifespan in schizophrenia: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

The glutamatergic dysfunction hypothesis for schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Metabotropic glutamate receptors in the basal ganglia motor circuit

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Group 5 metabotropic glutamate receptors: role in modulating cortical activity and relevance to cognition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Recent patents on positive allosteric modulators of the metabotropic glutamate 5 receptor as a potential treatment for schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Targeting of metabotropic glutamate receptors for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activiti

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Direct effects of metabotropic glutamate receptor compounds on native and recombinant N-methyl-D-aspartate receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Genes, dopamine and cortical signal-to-noise ratio in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01045.X

21 January 2018

Identifiers

10.1111/J.1472-8206.2012.01045.X

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22594375

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47989124&oldid=2180700115"